First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.

about

First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.

Item

http://www.wikidata.org/entity/Q38791698

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

First-line therapy for chronic ...... s: A FILO retrospective study.

@en

type

Item

label

First-line therapy for chronic ...... s: A FILO retrospective study.

@en

prefLabel

First-line therapy for chronic ...... s: A FILO retrospective study.

@en

P1476

First-line therapy for chronic ...... ts: A FILO retrospective study

@en

P2093

Anne Sophie Michallet

http://www.w3.org/2001/XMLSchema#string

Annie Brion

http://www.w3.org/2001/XMLSchema#string

Bruno Cazin

http://www.w3.org/2001/XMLSchema#string

Cécile Tomowiak

http://www.w3.org/2001/XMLSchema#string

Daniel Ré

http://www.w3.org/2001/XMLSchema#string

Florence Cymbalista

http://www.w3.org/2001/XMLSchema#string

Godelieve Meunier

http://www.w3.org/2001/XMLSchema#string

Jehan Dupuis

http://www.w3.org/2001/XMLSchema#string

Loic Ysebaert

http://www.w3.org/2001/XMLSchema#string

Marie Christine Béné

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.

Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.

Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712

Management and geriatric assessment of cancer in the elderly.

P304

671-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HON.2370

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guillaume Cartron

Anne Quinquenel

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27878835

http://www.w3.org/2001/XMLSchema#string